# Glycopyrrolate

NDC: 76045-223
Generic name: Glycopyrrolate
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20220421

FDA application: NDA214919

## Active ingredients

- GLYCOPYRROLATE: .2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76045-223"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76045-223
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=685aaf64-1a64-42f9-a96f-4764d650c26f